doxycycline plus metronidazole

PreclinicalSmall molecule

doxycycline plus metronidazole is one of 4 small molecule programs targeting Septic Abortion. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Septic AbortionActive, not recruiting

Septic AbortionPreclinical

Active, not recruiting

Competition

Competitive Landscape

3 competitors in Septic Abortion

#DrugCompanyPhaseTrials

Acanya

Pfizer

Approved

1 2

Vibramycin

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Flagyl

doxycycline plus metronidazole

HHospital de Clinicas de Porto Alegre

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Septic Abortion1 trial

The Use of Antibiotics After Hospital Discharge in Septic Abortion

Terminated·HHospital de Clinicas de Porto Alegre·N/A·NCT00353743·56 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for doxycycline plus metronidazole. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — doxycycline plus metronidazole compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for doxycycline plus metronidazole. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hospital de Clinicas de Porto Alegre company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: HHospital de Clinicas de Porto Alegre

doxycycline plus metronidazole

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Septic Abortion1 trial

References

Drug Info

Quick Facts

Related News